Skip Header

You are using a version of Internet Explorer that may not display all features of this website. Please upgrade to a modern browser.
Contribute Send feedback
Read comments (?) or add your own

Q04900 (MUC24_HUMAN) Reviewed, UniProtKB/Swiss-Prot

Last modified April 16, 2014. Version 110. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (4) | Third-party data text xml rdf/xml gff fasta
to top of pageNames·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order

Names and origin

Protein namesRecommended name:
Sialomucin core protein 24

Short name=MUC-24
Alternative name(s):
Endolyn
Multi-glycosylated core protein 24
Short name=MGC-24
Short name=MGC-24v
CD_antigen=CD164
Gene names
Name:CD164
OrganismHomo sapiens (Human) [Reference proteome]
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length197 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is further processed into a mature form.
Protein existenceEvidence at protein level

General annotation (Comments)

Function

Sialomucin that may play a key role in hematopoiesis by facilitating the adhesion of CD34+ cells to the stroma and by negatively regulating CD34+CD38(lo/-) cell proliferation. Modulates the migration of umbilical cord blood CD133+ cells and this is mediated through the CXCL12/CXCR4 axis. May play an important role in prostate cancer metastasis and the infiltration of bone marrow by cancer cells. Promotes myogenesis by enhancing CXCR4-dependent cell motility. Positively regulates myoblast migration and promotes myoblast fusion into myotubes By similarity. Ref.2 Ref.9 Ref.10

Subunit structure

Homodimer (isoform 4) Interacts with CXCR4. Ref.2 Ref.10

Subcellular location

Lysosome membrane; Single-pass type I membrane protein. Endosome membrane; Single-pass type I membrane protein. Cell membrane; Single-pass type I membrane protein Ref.4.

Isoform 2: Secreted Potential Ref.4.

Tissue specificity

Isoform 1 and isoform 3 are expressed in hematopoietic and non-hematopoietic tissues. Isoform 1 is expressed by prostate cancer tumors and prostate cancer cell lines. The expression is greater in bone metastases than in primary tumors. Expression in osseous metastasis is greater than that in soft tissue metastasis. Isoform 2 is expressed in the small intestine, colon, lung, thyroid and in colorectal and pancreatic adenocarcinoma. Isoform 4 is expressed by both hematopoietic progenitor cells and bone marrow stromal cells. Ref.1 Ref.2 Ref.3 Ref.4 Ref.9

Induction

Up-regulated by CXCL12 in prostate cancer cell lines. Ref.9

Post-translational modification

Highly N- and O-glycosylated; contains sialic acid. Ref.1

The motif Ser-Gly may serve as the site of attachment of a glycosaminoglycan side chain.

Sequence similarities

Belongs to the CD164 family.

Ontologies

Keywords
   Biological processCell adhesion
Myogenesis
   Cellular componentCell membrane
Endosome
Lysosome
Membrane
Secreted
   Coding sequence diversityAlternative splicing
   DomainSignal
Transmembrane
Transmembrane helix
   PTMGlycoprotein
   Technical termComplete proteome
Reference proteome
Gene Ontology (GO)
   Biological_processcell adhesion

Inferred from direct assay PubMed 10491205. Source: MGI

hemopoiesis

Non-traceable author statement Ref.4. Source: UniProtKB

heterophilic cell-cell adhesion

Inferred from direct assay PubMed 10491205. Source: MGI

immune response

Traceable author statement Ref.2. Source: ProtInc

multicellular organismal development

Traceable author statement PubMed 9680353. Source: ProtInc

muscle organ development

Inferred from electronic annotation. Source: UniProtKB-KW

negative regulation of cell adhesion

Non-traceable author statement Ref.3. Source: UniProtKB

negative regulation of cell proliferation

Non-traceable author statement Ref.3. Source: UniProtKB

signal transduction

Traceable author statement Ref.2. Source: ProtInc

   Cellular_componentendosome

Inferred from direct assay Ref.4. Source: UniProtKB

endosome membrane

Inferred from electronic annotation. Source: UniProtKB-SubCell

extracellular region

Inferred from electronic annotation. Source: UniProtKB-SubCell

integral component of plasma membrane

Non-traceable author statement Ref.4. Source: UniProtKB

lysosomal membrane

Inferred from electronic annotation. Source: UniProtKB-SubCell

lysosome

Inferred from direct assay Ref.4. Source: UniProtKB

plasma membrane

Inferred from direct assay PubMed 10491205. Source: MGI

Complete GO annotation...

Binary interactions

With

Entry

#Exp.

IntAct

Notes

CXCR4P610732EBI-2115896,EBI-489411

Alternative products

This entry describes 5 isoforms produced by alternative splicing. [Align] [Select]
Isoform 1 (identifier: Q04900-1)

Also known as: CD164(E1-6);

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Isoform 2 (identifier: Q04900-2)

The sequence of this isoform differs from the canonical sequence as follows:
     175-197: GVQAVIFFLYKFCKSKERNYHTL → EIRCHTRNYIPDLKK
Isoform 3 (identifier: Q04900-3)

Also known as: CD164(Delta 4);

The sequence of this isoform differs from the canonical sequence as follows:
     111-123: Missing.
Isoform 4 (identifier: Q04900-4)

Also known as: CD164(Delta 5);

The sequence of this isoform differs from the canonical sequence as follows:
     124-142: Missing.
Isoform 5 (identifier: Q04900-5)

The sequence of this isoform differs from the canonical sequence as follows:
     143-157: GTTNNTVTPTSQPVR → EIRCHTRNYIPDLKK
     158-197: Missing.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Signal peptide1 – 2323 Potential
Chain24 – 197174Sialomucin core protein 24
PRO_0000019292

Regions

Topological domain24 – 162139Extracellular Potential
Transmembrane163 – 18321Helical; Potential
Topological domain184 – 19714Cytoplasmic Potential
Region191 – 1977Required for endosomal and lysosomal localization By similarity
Compositional bias105 – 15248Thr-rich

Amino acid modifications

Glycosylation261N-linked (GlcNAc...) Potential
Glycosylation321N-linked (GlcNAc...) Potential
Glycosylation411N-linked (GlcNAc...) Potential
Glycosylation721N-linked (GlcNAc...) Potential
Glycosylation771N-linked (GlcNAc...) Potential
Glycosylation941N-linked (GlcNAc...) Potential
Glycosylation1041N-linked (GlcNAc...) Potential
Glycosylation1211N-linked (GlcNAc...) Potential
Glycosylation1421O-linked (Xyl...) (glycosaminoglycan) Potential
Glycosylation1461N-linked (GlcNAc...) Potential

Natural variations

Alternative sequence111 – 12313Missing in isoform 3.
VSP_037972
Alternative sequence124 – 14219Missing in isoform 4.
VSP_037973
Alternative sequence143 – 15715GTTNN…SQPVR → EIRCHTRNYIPDLKK in isoform 5.
VSP_038018
Alternative sequence158 – 19740Missing in isoform 5.
VSP_038019
Alternative sequence175 – 19723GVQAV…NYHTL → EIRCHTRNYIPDLKK in isoform 2.
VSP_037974

Sequences

Sequence LengthMass (Da)Tools
Isoform 1 (CD164(E1-6)) [UniParc].

Last modified September 1, 2009. Version 2.
Checksum: 4855E02646F4CB35

FASTA19720,917
        10         20         30         40         50         60 
MSRLSRSLLW AATCLGVLCV LSADKNTTQH PNVTTLAPIS NVTSAPVTSL PLVTTPAPET 

        70         80         90        100        110        120 
CEGRNSCVSC FNVSVVNTTC FWIECKDESY CSHNSTVSDC QVGNTTDFCS VSTATPVPTA 

       130        140        150        160        170        180 
NSTAKPTVQP SPSTTSKTVT TSGTTNNTVT PTSQPVRKST FDAASFIGGI VLVLGVQAVI 

       190 
FFLYKFCKSK ERNYHTL 

« Hide

Isoform 2 [UniParc].

Checksum: AC1E49F139D50B10
Show »

FASTA18920,011
Isoform 3 (CD164(Delta 4)) [UniParc].

Checksum: FB689B760D2EE1FC
Show »

FASTA18419,689
Isoform 4 (CD164(Delta 5)) [UniParc].

Checksum: 06FC14ECF6372314
Show »

FASTA17819,017
Isoform 5 [UniParc].

Checksum: 9F0212BE11D4F958
Show »

FASTA15716,736

References

« Hide 'large scale' references
[1]"A novel core protein as well as polymorphic epithelial mucin carry peanut agglutinin binding sites in human gastric carcinoma cells: sequence analysis and examination of gene expression."
Masuzawa Y., Miyauchi T., Hamanoue M., Ando S., Yoshida J., Takao S., Shimazu H., Adachi M., Muramatsu T.
J. Biochem. 112:609-615(1992) [PubMed] [Europe PMC] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, GLYCOSYLATION.
Tissue: Gastric carcinoma.
[2]"The sialomucin CD164 (MGC-24v) is an adhesive glycoprotein expressed by human hematopoietic progenitors and bone marrow stromal cells that serves as a potent negative regulator of hematopoiesis."
Zannettino A.C.W., Buehring H.-J., Niutta S., Watt S.M., Benton M.A., Simmons P.J.
Blood 92:2613-2628(1998) [PubMed] [Europe PMC] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), FUNCTION, SUBUNIT, TISSUE SPECIFICITY.
Tissue: Bone marrow.
[3]"CD164 monoclonal antibodies that block hemopoietic progenitor cell adhesion and proliferation interact with the first mucin domain of the CD164 receptor."
Doyonnas R., Chan J.Y.-H., Butler L.H., Rappold I., Lee-Prudhoe J.E., Zannettino A.C.W., Simmons P.J., Buehring H.-J., Levesque J.-P., Watt S.M.
J. Immunol. 165:840-851(2000) [PubMed] [Europe PMC] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY.
[4]"Relationship between novel isoforms, functionally important domains, and subcellular distribution of CD164/endolyn."
Chan J.Y.-H., Lee-Prudhoe J.E., Jorgensen B., Ihrke G., Doyonnas R., Zannettino A.C.W., Buckle V.J., Ward C.J., Simmons P.J., Watt S.M.
J. Biol. Chem. 276:2139-2152(2001) [PubMed] [Europe PMC] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1; 3 AND 4), ALTERNATIVE SPLICING, SUBCELLULAR LOCATION, TISSUE SPECIFICITY.
[5]"Complete sequencing and characterization of 21,243 full-length human cDNAs."
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. expand/collapse author list , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.
Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3; 4 AND 5).
Tissue: Amygdala, Astrocyte, Neutrophil and Thymus.
[6]"The DNA sequence and analysis of human chromosome 6."
Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., Andrews T.D. expand/collapse author list , Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V., Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J., Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J., French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M., Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.
Nature 425:805-811(2003) [PubMed] [Europe PMC] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[7]Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. expand/collapse author list , Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W., Venter J.C.
Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[8]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
Tissue: Colon.
[9]"The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis."
Havens A.M., Jung Y., Sun Y.X., Wang J., Shah R.B., Buehring H.J., Pienta K.J., Taichman R.S.
BMC Cancer 6:195-195(2006) [PubMed] [Europe PMC] [Abstract]
Cited for: FUNCTION, INDUCTION, TISSUE SPECIFICITY.
[10]"Endolyn (CD164) modulates the CXCL12-mediated migration of umbilical cord blood CD133+ cells."
Forde S., Tye B.J., Newey S.E., Roubelakis M., Smythe J., McGuckin C.P., Pettengell R., Watt S.M.
Blood 109:1825-1833(2007) [PubMed] [Europe PMC] [Abstract]
Cited for: FUNCTION, INTERACTION WITH CXCR4.
+Additional computationally mapped references.

Cross-references

Sequence databases

EMBL
GenBank
DDBJ
D14043 mRNA. Translation: BAA03130.1.
AF106518 mRNA. Translation: AAC82473.1.
AF263279 mRNA. Translation: AAF85965.1.
AF299341 mRNA. Translation: AAG53906.1.
AF299342 mRNA. Translation: AAG53907.1.
AF299343 mRNA. Translation: AAG53908.1.
AF299340 Genomic DNA. Translation: AAG53903.1.
AF299340 Genomic DNA. Translation: AAG53904.1.
AF299340 Genomic DNA. Translation: AAG53905.1.
AK298684 mRNA. Translation: BAG60847.1.
AK303525 mRNA. Translation: BAG64553.1.
AK312357 mRNA. Translation: BAG35275.1.
AK315908 mRNA. Translation: BAH14279.1.
AL359711 Genomic DNA. Translation: CAI40700.1.
AL359711 Genomic DNA. Translation: CAI40702.1.
AL359711 Genomic DNA. Translation: CAI40704.1.
CH471051 Genomic DNA. Translation: EAW48348.1.
CH471051 Genomic DNA. Translation: EAW48352.1.
CH471051 Genomic DNA. Translation: EAW48349.1.
CH471051 Genomic DNA. Translation: EAW48353.1.
CH471051 Genomic DNA. Translation: EAW48354.1.
CH471051 Genomic DNA. Translation: EAW48355.1.
BC011522 mRNA. Translation: AAH11522.1.
PIRJX0235.
RefSeqNP_001135873.1. NM_001142401.1.
NP_001135874.1. NM_001142402.1.
NP_001135875.1. NM_001142403.1.
NP_001135876.1. NM_001142404.1.
NP_006007.2. NM_006016.4.
UniGeneHs.520313.

3D structure databases

ProteinModelPortalQ04900.
ModBaseSearch...
MobiDBSearch...

Protein-protein interaction databases

BioGrid114297. 2 interactions.
IntActQ04900. 9 interactions.
MINTMINT-5225006.
STRING9606.ENSP00000309376.

Polymorphism databases

DMDM257051036.

Proteomic databases

PaxDbQ04900.
PRIDEQ04900.

Protocols and materials databases

DNASU8763.
StructuralBiologyKnowledgebaseSearch...

Genome annotation databases

EnsemblENST00000275080; ENSP00000275080; ENSG00000135535. [Q04900-3]
ENST00000310786; ENSP00000309376; ENSG00000135535. [Q04900-1]
ENST00000324953; ENSP00000314177; ENSG00000135535. [Q04900-4]
ENST00000413644; ENSP00000402237; ENSG00000135535. [Q04900-2]
ENST00000512821; ENSP00000427546; ENSG00000135535. [Q04900-5]
GeneID8763.
KEGGhsa:8763.
UCSCuc003ptd.3. human. [Q04900-2]
uc003pte.3. human. [Q04900-1]
uc003ptf.3. human. [Q04900-4]
uc010kdn.3. human. [Q04900-3]
uc011eap.2. human. [Q04900-5]

Organism-specific databases

CTD8763.
GeneCardsGC06M109687.
HGNCHGNC:1632. CD164.
HPAHPA010636.
MIM603356. gene.
neXtProtNX_Q04900.
PharmGKBPA26191.
GenAtlasSearch...

Phylogenomic databases

eggNOGNOG77756.
HOVERGENHBG052534.
KOK06546.
OrthoDBEOG7XDBJ6.
PhylomeDBQ04900.
TreeFamTF333380.

Gene expression databases

ArrayExpressQ04900.
BgeeQ04900.
CleanExHS_CD164.
GenevestigatorQ04900.

Family and domain databases

InterProIPR007947. CD164_MGC24.
[Graphical view]
PANTHERPTHR11337:SF8. PTHR11337:SF8. 1 hit.
PfamPF05283. MGC-24. 1 hit.
[Graphical view]
PRINTSPR01701. CD164ANTIGEN.
ProtoNetSearch...

Other

ChiTaRSCD164. human.
GeneWikiCD164.
GenomeRNAi8763.
NextBio32868.
PROQ04900.
SOURCESearch...

Entry information

Entry nameMUC24_HUMAN
AccessionPrimary (citable) accession number: Q04900
Secondary accession number(s): B4DQ85 expand/collapse secondary AC list , E1P5E7, E1P5E8, E1P5E9, O95413, Q5JSU6, Q9BPV0, Q9NR26
Entry history
Integrated into UniProtKB/Swiss-Prot: June 1, 1994
Last sequence update: September 1, 2009
Last modified: April 16, 2014
This is version 110 of the entry and version 2 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Relevant documents

SIMILARITY comments

Index of protein domains and families

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

Human chromosome 6

Human chromosome 6: entries, gene names and cross-references to MIM

Human cell differentiation molecules

CD nomenclature of surface proteins of human leucocytes and list of entries